AB
LXRX icon

Amalgamated Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History

Amalgamated Bank’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,409
Closed -$1K – 3083
2025
Q1 		$1K Hold
2,409
– – ﹤0.01% 2917
2024
Q4 		$2K Hold
2,409
– – ﹤0.01% 2909
2024
Q3 		$4K Hold
2,409
– – ﹤0.01% 2827
2024
Q2 		$4K Hold
2,409
– – ﹤0.01% 2862
2024
Q1 		$6K Sell
2,409
-7,538
-76% -$16.2K ﹤0.01% 2653
2023
Q4 		$15K Sell
9,947
-717
-7% -$853 ﹤0.01% 2767
2023
Q3 		$12K Hold
10,664
– – ﹤0.01% 2858
2023
Q2 		$24K Buy
10,664
+1,553
+17% +$4.12K ﹤0.01% 2653
2023
Q1 		$22K Sell
9,111
-1,926
-17% -$4.41K ﹤0.01% 2609
2022
Q4 		$21K Hold
11,037
– – ﹤0.01% 2738
2022
Q3 		$26K Buy
11,037
+1,113
+11% +$3.08K ﹤0.01% 2731
2022
Q2 		$18K Buy
9,924
+303
+3% +$578 ﹤0.01% 2880
2022
Q1 		$20K Sell
9,621
-683
-7% -$1.89K ﹤0.01% 2810
2021
Q4 		$41K Sell
10,304
-149
-1% -$724 ﹤0.01% 2115
2021
Q3 		$50K Sell
10,453
-415
-4% -$1.7K ﹤0.01% 2133
2021
Q2 		$50K Buy
+10,868
New +$52.3K ﹤0.01% 2163
2015
Q2 		– Sell
-3,131
Closed -$21K – 1371
2015
Q1 		$21K Buy
3,131
+13
+0.4% +$89 ﹤0.01% 930
2014
Q4 		$20K Buy
3,118
+204
+7% +$1.64K ﹤0.01% 853
2014
Q3 		$29K Buy
2,914
+11
+0.4% +$117 ﹤0.01% 835
2014
Q2 		$33K Sell
2,903
-250
-8% -$2.69K 0.01% 865
2014
Q1 		$38K Sell
3,153
-16
-0.5% -$204 0.01% 826
2013
Q4 		$40K Buy
+3,169
New +$50.4K 0.01% 828

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amalgamated Bank's LXRX Position: Q2 2025 in Review

Amalgamated Bank sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2025, closing a stake of 2,409 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in LXRX in Q4 2013 and held it in 22 quarters. The position peaked at $50K in Q3 2021. 123 funds tracked by Wall St. Rank hold LXRX as of Q2 2025.

  • Amalgamated Bank reported no remaining Lexicon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 2,409 Lexicon Pharmaceuticals shares in Q2 2025, an estimated $1K.
  • Amalgamated Bank first reported a position in Lexicon Pharmaceuticals in Q4 2013 and held it in 22 quarters.
  • Amalgamated Bank's Lexicon Pharmaceuticals position peaked at $50K in Q3 2021.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.